Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Reboot Pain (tDCS)

NCT: NCT07411859 · RECRUITING

NCT IDNCT07411859
StatusRECRUITING
Start Date2026-02-16
Completion2027-05

Brief Summary

This study will examine the effectiveness of tDCS (Transcranial Direct Current Stimulation) in reducing chronic pain when used with Emory Healthcare Veterans Program (EHVP)-ABHP (Accelerated Behavioral Health Program) participants as measured by the Pain, Enjoyment of Life and General Activity Scale (PEG).

Frequently Asked Questions

What is Reboot Pain (tDCS)?

Reboot Pain (tDCS) is a clinical trial registered under NCT07411859. Current status: RECRUITING.

What is the status of NCT07411859?

The current status of NCT07411859 (Reboot Pain (tDCS)) is: RECRUITING.

When did Reboot Pain (tDCS) start?

Reboot Pain (tDCS) started on 2026-02-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.